For his scalp, he was prescribed betamethasone ... Five percent to 20% of cases of cutaneous psoriasis are accompanied by psoriatic arthritis that can be debilitating. Thus, psoriasis deserves ...

The study was conducted among patients with plaque psoriasis affecting special areas such as the scalp, genitals and ... also be evaluated in psoriasis arthritis early next year.

Topline results were announced from a phase 3 trial evaluating icotrokinra in patients with moderate to severe plaque psoriasis (PsO).

Plaque psoriasis causes thick red or dark-colored patches of skin on the elbows, knees, lower back, or scalp. These patches ... causes symptoms of psoriatic arthritis. By reducing this ...

Autoimmune diseases affect millions of people worldwide, often in ways that can be life-altering. These conditions occur when ...

Your provider will complete a close-up examination of your skin and scalp, often using a dermatoscope ... Nearly one-third of people with psoriasis develop inflammatory arthritis. Your provider will ...

Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and ... American Academy of Dermatology Association. Scalp Psoriasis: Shampoo, Scale Softeners, and Other ...

Conclusion: Patients with psoriasis had suboptimal knowledge, positive attitude and inactive practice toward psoriatic arthritis. To address this ... typically localized to the scalp, extensor ...

“Foods high on the glycemic index [such as processed, sugary foods] will exacerbate primary skin diseases from acne to ...

Deucravacitinib outperformed placebo for treating moderate to severe scalp psoriasis, even among patients with less extensive overall disease.

Secukinumab is indicated for treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic ...

Deucravacitinib was safe and effective for treating moderate to severe scalp psoriasis over 16 weeks, even among patients with less extensive overall disease. Deucravacitinib demonstrates ...